[Federal Register Volume 66, Number 122 (Monday, June 25, 2001)]
[Notices]
[Page 33715]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15834]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 20, 2000, and published in the Federal 
Register on November 5, 2000, (65 FR 75959), Knoll Pharmaceutical 
Company, 30 North Jefferson Road, Whippany, New Jersey 07981, made 
application by renewal to the Drug Enforcement Administration to be 
registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    The firm plans to produce bulk product and finished dosage units 
for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Knoll Pharmaceutical Company to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Knoll Pharmaceutical 
Company on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: June 4, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-15834 Filed 6-22-01; 8:45 am]
BILLING CODE 4410-09-M